Trump Highlights Health Agenda With Vow To Lower 鈥楿nfair鈥 Drug Prices
The president laid out a series of goals, including lowering prescription prices, pursuing an end to the HIV epidemic and boosting funding for childhood cancers.
Drugs
861-880 of 1,318 results
-
-
Winners And Losers Under Bold Trump Plan To Slash Drug Rebate Deals
The White House and HHS want to eliminate a 鈥渟hadowy system of kickbacks鈥 in the drug industry pipeline.
By Jay Hancock -
Lawsuit Details How The Sackler Family Allegedly Built An OxyContin Fortune
WBUR and other media organizations sued Purdue Pharma to force the release of previously redacted information in a case brought by the Massachusetts attorney general.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 Live From D.C.: A Look Ahead At Health Policy In 2019
Congress and President Donald Trump are starting to wrestle with health policy issues, and health is already a key debate point in the early run-up to the 2020 Democratic presidential primaries. Might any major health policy legislation be passed and signed this year? Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of The Washington Examiner, along with special guest Tom Miller of the American Enterprise Institute, join KHN鈥檚 Julie Rovner to discuss these issues and take questions from a live studio audience.
-
Congress Wades Into Emotional Debate Over High-Cost Prescription Drugs
Key House and Senate committees kick off hearings on drug prices, and patients鈥 families weigh in with tragic stories.
By Emmarie Huetteman and Rachel Bluth -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Drug-Pricing Policies Find New Momentum As 鈥楢 2020 Thing鈥
Emboldened by midterm election results and interest in possible presidential runs, Democrats are advancing a slew of new and old legislative proposals. It鈥檚 not yet clear, though, which if any could go the distance.
-
Listen: ‘Death Certificate Project’ Aims At Opioid Crisis, But Doctors Cry Foul
A radio report on an effort in California to hold doctors responsible when a patient overdoses on opioids. Doctors say it is unfair, but the state medical board defends the new project.
-
Doctors Call California鈥檚 Probe Of Opioid Deaths A 鈥榃itch Hunt鈥
In a unique crackdown on what it sees as 鈥渆xcessive prescribing,鈥 the state medical board is investigating hundreds of doctors whose patients ultimately died of opioid overdoses 鈥 whether or not the doctors prescribed the fatal medications.
By Cheryl Clark -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
County By County, Researchers Link Opioid Deaths To Drugmakers鈥 Marketing
A JAMA study looking at county-specific federal data finds that the more opioid-related marketing dollars spent in a county, the higher rates of doctors who prescribed those drugs, and ultimately, more overdose deaths.
-
Secretive 鈥楻ebate Trap鈥 Keeps Generic Drugs For Diabetes And Other Ills Out Of Reach
Patients are often forced into using brand names because drug formularies favor them over cheaper competitors.
By Jay Hancock and Sydney Lupkin -
Podcast: KHN’s ‘What The Health?’ Drug Prices Are Rising Again. Is Someone Going To Do Something About It?
As drugmakers hike prices, interest to rein them in grows on Capitol Hill. Next week marks the anniversary of Roe v. Wade, the Supreme Court鈥檚 abortion decision, and both the House, whose leaders back abortion rights, and the Senate, controlled by abortion foes, are holding statement votes. And the government shutdown is still affecting health programs. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss these issues.
-
Meth鈥檚 Resurgence Spotlights Lack Of Meds To Combat The Addiction
While headlines continue to focus on the nation鈥檚 opioid crisis, a growing toll of overdoses and deaths related to methamphetamine use suggests this drug is making an under-the-radar comeback.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Bills, Bills, Bills: Readers And Tweeters Offer Solace, Solutions And Scoldings
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
Emergency Medical Responders Confront Racial Bias
In a recent study of patients treated by emergency medical responders in Oregon, black patients were 40 percent less likely to get pain medicine than their white peers. Why?
-
Extreme Temperatures May Pose Risks To Some Mail-Order Meds
Loretta Boesing is on a mission to make sure prescription drugs delivered by mail are safe and effective. The life of her son 鈥 and others who order medicine by mail 鈥 could depend on it, she says.
-
Health Care Industry Spends $30B A Year Pushing Its Wares, From Drugs To Stem Cell Treatment
Critics say patients are often misled by ads that advocate high-priced drugs or genetic tests.
By Liz Szabo